相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Expression of nucleoside transporters, deoxycitidine kinase, ribonucleotide reductase regulatory subunits, and gemcitabine catabolic enzymes in primary ovarian cancer
Gabriella Ferrandina et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets
N. Turner et al.
ONCOGENE (2010)
Genetic polymorphisms affecting clinical outcomes in epithelial ovarian cancer patients treated with taxanes and platinum compounds: A Korean population-based study
Hee Seung Kim et al.
GYNECOLOGIC ONCOLOGY (2009)
Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: implications for schizophrenia, autism and cancer
R. Tabares-Seisdedos et al.
MOLECULAR PSYCHIATRY (2009)
The NRG1 gene is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor gene
Y. L. Chua et al.
ONCOGENE (2009)
Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer
Erik Noetzel et al.
BMC CANCER (2008)
High definition cytogenetics and oligonucleotide aCGH analyses of cisplatin-resistant ovarian cancer cells
Mona Prasad et al.
GENES CHROMOSOMES & CANCER (2008)
Whole genome oligonucleotide-based array comparative genomic hybridization analysis identified fibroblast growth factor I as a prognostic marker for advanced-stage serous ovarian adenocarcinomas
Michael J. Birrer et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases
D. M. Owens et al.
ONCOGENE (2007)
Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer
Meera Nanjundan et al.
CANCER RESEARCH (2007)
Analysis of chromosomal changes in serous ovarian carcinoma using high-resolution array comparative genomic hybridization: Potential predictive markers of chemoresistant disease
Sang Wun Kim et al.
GENES CHROMOSOMES & CANCER (2007)
Chromosomal losses of regions on 5q and lack of high-level amplifications at 8q24 are associated with favorable prognosis for ovarian serous carcinoma
Annette Staebler et al.
GENES CHROMOSOMES & CANCER (2006)
High-resolution analysis of chromosome rearrangements on 8p in breast, colon and pancreatic cancer reveals a complex pattern of loss, gain and translocation
J. C. M. Pole et al.
ONCOGENE (2006)
Analysis of gene amplification and prognostic markers in ovarian cancer using comparative genomic hybridization for microarrays and immunohistochemical analysis for tissue microarrays
Doris Mayr et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2006)
Cytogenetic analysis of carboplatin resistance in early-stage epithelial ovarian carcinoma
L Österberg et al.
CANCER GENETICS AND CYTOGENETICS (2005)
NRG1 gene rearrangements in clinical breast cancer:: identification of an adjacent novel amplicon associated with poor prognosis
LM Prentice et al.
ONCOGENE (2005)
Differential gene expression in ovarian tumors reveals Dusp 4 and Serpina 5 as key regulators for benign behavior of serous borderline tumors
NLG Sieben et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Complex CGH alterations on chromosome arm 8p at candidate tumor suppressor gene loci in breast cancer cell lines
DJ Venter et al.
CANCER GENETICS AND CYTOGENETICS (2005)
High-resolution mapping of genomic imbalance and identification of gene expression profiles associated with differential chemotherapy response in serous epithelial ovarian cancer
M Bernardini et al.
NEOPLASIA (2005)
Gene-expression pro-files to predict distant metastasis of lymph-node-negative primary breast cancer
YX Wang et al.
LANCET (2005)
Variation in RNA expression and genomic DNA content acquired during cell culture
LR Hiorns et al.
BRITISH JOURNAL OF CANCER (2004)
Genomic microarrays in the spotlight
KK Mantripragada et al.
TRENDS IN GENETICS (2004)
High-resolution analysis of DNA copy number alterations in colorectal cancer by array-based comparative genomic hybridization
K Nakao et al.
CARCINOGENESIS (2004)
Influence of genetic markers on survival in non-small cell lung cancer
R Rosell et al.
DRUGS OF TODAY (2003)
Carcinoma of the ovary
APM Heintz et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2003)
Helix-loop-helix proteins in mammary gland development and breast cancer
PY Desprez et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2003)
Neuregulins: functions, forms, and signaling strategies
DL Falls
EXPERIMENTAL CELL RESEARCH (2003)
Detection of genetic alterations in Korean ovarian carcinomas by degenerate oligonucleotide primed polymerase chain reaction-comparative genomic hybridization
GJ Kim et al.
CANCER GENETICS AND CYTOGENETICS (2003)
Primary ovarian cancer chemotherapy: current standards of care
WP McGuire et al.
BRITISH JOURNAL OF CANCER (2003)
Molecular cytogenetic analysis of head and neck squamous cell carcinoma: By comparative genomic hybridization, spectral karyotyping, and expression array analysis
JA Squire et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2002)
Pancreatic tumor cells with mutant K-ras suppress ERK activity by MEK-dependent induction of MAP kinase phosphatase-2
MT Yip-Schneider et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach
C Beger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
CGH, cDNA and tissue microarray analyses implicate FGFR2 amplification in a small subset of breast tumors
M Heiskanen et al.
ANALYTICAL CELLULAR PATHOLOGY (2001)
Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: Three-year results
MJ Piccart et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)